Abstract
We tested four genes [phenylalanine hydroxylase (PAH), the serotonin transporter (SLC6A4), monoamine oxidase B (MAOB), and the gamma-aminobutyric acid A receptor beta-3 subunit (GABRB3)] for their impact on five schizophrenia symptom factors: delusions, hallucinations, mania, depression, and negative symptoms. In a 90 family subset of the Irish Study of High Density Schizophrenia Families, the PAH 232 bp microsatellite allele demonstrated significant association with the delusions factor using both QTDT (F=8.0, p=.031) and QPDTPHASE (chi-square=12.54, p=.028). Also, a significant association between the GABRB3 191 bp allele and the hallucinations factor was detected using QPDTPHASE (chi-square=15.51, p=.030), but not QTDT (chi-square=2.07, p=.560).
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Delusions / genetics
-
Family
-
Gene Frequency
-
Genetic Markers / genetics
-
Genetic Predisposition to Disease / genetics
-
Genetic Variation
-
Genome-Wide Association Study
-
Genotype
-
Hallucinations / genetics
-
Humans
-
Membrane Transport Proteins / genetics
-
Monoamine Oxidase / genetics*
-
Phenylalanine Hydroxylase / genetics*
-
Polymorphism, Genetic*
-
Polymorphism, Single Nucleotide
-
Psychotic Disorders / diagnosis
-
Psychotic Disorders / genetics*
-
Psychotic Disorders / psychology
-
Receptors, GABA / genetics
-
Schizophrenia / diagnosis
-
Schizophrenia / genetics
-
Serotonin Plasma Membrane Transport Proteins / genetics*
Substances
-
Genetic Markers
-
Membrane Transport Proteins
-
Receptors, GABA
-
SLC6A4 protein, human
-
Serotonin Plasma Membrane Transport Proteins
-
Phenylalanine Hydroxylase
-
Monoamine Oxidase